MX376004B - Proceso para mejorar las cuentas viables de bacterias de acido lactico y composiciones utiles de las mismas. - Google Patents

Proceso para mejorar las cuentas viables de bacterias de acido lactico y composiciones utiles de las mismas.

Info

Publication number
MX376004B
MX376004B MX2017002452A MX2017002452A MX376004B MX 376004 B MX376004 B MX 376004B MX 2017002452 A MX2017002452 A MX 2017002452A MX 2017002452 A MX2017002452 A MX 2017002452A MX 376004 B MX376004 B MX 376004B
Authority
MX
Mexico
Prior art keywords
lactic acid
acid bacteria
useful compositions
mtcc
viable counts
Prior art date
Application number
MX2017002452A
Other languages
English (en)
Other versions
MX2017002452A (es
Inventor
Furqan Ali
Muhammed Majeed
Sivakumar Arumugam
Original Assignee
Sami Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Labs Ltd filed Critical Sami Labs Ltd
Publication of MX2017002452A publication Critical patent/MX2017002452A/es
Publication of MX376004B publication Critical patent/MX376004B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención descrita aquí describe (i) el crecimiento de actividad promocional a base de planta natural sobre Bacillus coagulans MTCC 5856; (ii) la combinación de fibras a base de planta natural y Bacillus coagulans MTCC 5856 para inhibir la bacteria patogénica Gram Negativa y (iii) la producción de ácidos grasos de cadena corta (SCFA) mediante Bacillus coagulans MTCC 5856 usando fibras naturales a base de planta.
MX2017002452A 2014-08-29 2015-08-29 Proceso para mejorar las cuentas viables de bacterias de acido lactico y composiciones utiles de las mismas. MX376004B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462043599P 2014-08-29 2014-08-29
US201462063453P 2014-10-14 2014-10-14
PCT/US2015/047608 WO2016033572A1 (en) 2014-08-29 2015-08-29 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

Publications (2)

Publication Number Publication Date
MX2017002452A MX2017002452A (es) 2017-10-23
MX376004B true MX376004B (es) 2025-03-07

Family

ID=55400730

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002452A MX376004B (es) 2014-08-29 2015-08-29 Proceso para mejorar las cuentas viables de bacterias de acido lactico y composiciones utiles de las mismas.

Country Status (14)

Country Link
US (2) US9717766B2 (es)
EP (1) EP3185877B1 (es)
JP (1) JP6630723B2 (es)
KR (1) KR102089566B1 (es)
CN (1) CN106573021B (es)
AU (1) AU2015308650B2 (es)
CA (1) CA2955111A1 (es)
EA (1) EA034017B1 (es)
MX (1) MX376004B (es)
MY (1) MY174855A (es)
PH (1) PH12017500059B1 (es)
PL (1) PL3185877T3 (es)
SG (1) SG11201700006UA (es)
WO (1) WO2016033572A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10609935B2 (en) * 2017-05-26 2020-04-07 Sami Labs Limited Beverage compositions containing Bacillus coagulans MTCC 5856
US11525116B2 (en) 2018-04-17 2022-12-13 Bien-Etre Labs, LLC Date palm medium compositions and methods
CN110537573A (zh) * 2018-05-28 2019-12-06 可口可乐公司 一种含孢子型凝结芽孢杆菌的常温酸性饮品的生产方法
WO2020231397A1 (en) * 2019-05-13 2020-11-19 Muhammed Majeed Fructophilic lactic acid producing bacteria
CN110268847A (zh) * 2019-06-05 2019-09-24 云南大学 一种免腐熟生饼粕肥直接施用方法
CN110800438A (zh) * 2019-11-25 2020-02-18 广东海纳肥业有限公司 一种油柑的施肥方法
US20240141284A1 (en) * 2021-03-03 2024-05-02 Bien-Etre Labs, LLC Compositions and methods for cultivating environmental microorganisms and compositions derived therefrom

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69842080D1 (de) * 1997-04-18 2011-02-10 Ganeden Biotech Inc Oberflächige Verwendung von probiotischen Bacillussporen zur Verhinderung oder Bekämpfung von mikrobiellen Infektionen
WO1999049877A2 (en) * 1998-04-01 1999-10-07 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
ATE293895T1 (de) * 1999-10-29 2005-05-15 Hunza Di Pistolesi Elvira E C Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
US9101148B2 (en) * 2001-05-25 2015-08-11 Sbs Food Group Llc Carbohydrate modifying agent and drinks containing the modifying agent
US20030004211A1 (en) * 2001-05-25 2003-01-02 Frank Corsini Carbohydrate modifying agent and drinks containing the modifying agent
US20040197277A1 (en) * 2001-08-24 2004-10-07 The Procter & Gamble Company Chewable compositions with probiotic agents
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
AU2004267383A1 (en) * 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
CN101541947B (zh) * 2006-08-04 2013-03-13 株式会社百奥尼 分离自母乳的具有益生菌活性和抑制体重增加活性的乳酸菌
KR101003654B1 (ko) * 2008-08-27 2010-12-23 삼성전기주식회사 반도체 패키지용 트랜스포머
US20120076895A1 (en) * 2009-04-23 2012-03-29 Bacterfield Ou Extruded food products comprising probiotic micro-organisms
CN101792727B (zh) * 2010-04-02 2012-05-30 上海交通大学 一株凝结芽孢杆菌及其在l-乳酸钠制备中的应用
CN102690764B (zh) * 2010-05-20 2013-07-10 上海交通大学 用于制备l-乳酸的凝结芽孢杆菌及其应用方法
WO2012135499A1 (en) * 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
DK2773744T3 (en) * 2011-11-02 2019-04-08 Univ Texas Tech System Media compositions to promote bacterial and fungal growth
US20150299516A1 (en) * 2012-11-26 2015-10-22 Progel Pty Ltd Coating composition
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US9596861B2 (en) * 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof

Also Published As

Publication number Publication date
SG11201700006UA (en) 2017-01-27
WO2016033572A8 (en) 2017-02-02
US20160058805A1 (en) 2016-03-03
PL3185877T3 (pl) 2020-11-02
JP6630723B2 (ja) 2020-01-15
PH12017500059A1 (en) 2017-05-15
AU2015308650A1 (en) 2017-02-16
CA2955111A1 (en) 2016-03-03
WO2016033572A1 (en) 2016-03-03
EP3185877A1 (en) 2017-07-05
EP3185877B1 (en) 2020-04-01
AU2015308650B2 (en) 2018-04-05
CN106573021A (zh) 2017-04-19
CN106573021B (zh) 2020-09-11
EP3185877A4 (en) 2018-04-25
US10293008B2 (en) 2019-05-21
MY174855A (en) 2020-05-19
KR102089566B1 (ko) 2020-03-16
US20170274023A1 (en) 2017-09-28
EA201692563A1 (ru) 2017-07-31
AU2015308650A8 (en) 2017-02-23
US9717766B2 (en) 2017-08-01
EA034017B1 (ru) 2019-12-19
PH12017500059B1 (en) 2017-05-15
JP2017532017A (ja) 2017-11-02
KR20170020913A (ko) 2017-02-24
MX2017002452A (es) 2017-10-23

Similar Documents

Publication Publication Date Title
MX376004B (es) Proceso para mejorar las cuentas viables de bacterias de acido lactico y composiciones utiles de las mismas.
MX383709B (es) Microbios, composiciones y consorcios microbianos beneficiosos para la agricultura.
PH12014501282A1 (en) Plant growth-promoting microbes and uses therefor
CO2017001998A2 (es) Proceso para incrementar la producción de biomasa y esporas de bacterias promotoras del crecimiento vegetal del género bacillus.
MX395585B (es) Composiciones producidas por microorganismos con actividad estimuladora sobre las plantas
MX388051B (es) Microbios, composiciones de microbios, y consorcios beneficiosos para la agricultura.
MX391417B (es) Métodos para mejorar la producción agrícola de aves de corral mediante la administración de consorcios microbianos o cepas purificadas de los mismos.
PH12015500604B1 (en) Processing biomass
MX2023003789A (es) Celulas microbianas, metodos para producir las mismas, y usos de las mismas.
PH12015500599A1 (en) Processing biomass
CL2017001329A1 (es) Conjunto bacteriano sinergístico destinado a movilizar el fósforo del suelo.
CL2017002320A1 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
EA201990128A1 (ru) Культуры клеточных линий из растений, принадлежащих к роду harpagophytum
UA113957C2 (xx) Застосування емульгаторів в поєднанні з рослинними олеїнами в кормі для тварин
MX2013012045A (es) Péptidos con actividad antimicrobiana, composiciones farmacéuticas para la profilaxis y el tratamiento de animales, composiciones para la profilaxis y el tratamiento de vegetales, usos de esos péptidos y usos del extracto de paenibacillus elgii ourofinensis.
EA201300900A1 (ru) Способы и композиции для уменьшения слипания семян
MA39892A (fr) Utilisation d'un acide dicarboxylique pour lutter contre la croissance de plantes holoparasites ou hémiparasites
UY33940A (es) Compuestos de androstan útiles como reguladores del crecimiento de las plantas, métodos para su producción y usos.
MX391845B (es) Composiciones agroquimicas y metodos para elaborar y utilizar las mismas.
AR109444A1 (es) Un procedimiento para la producción industrial de lípidos a partir de residuos orgánicos utilizando diferentes bacterias del género rhodococcus
BR112017023724A2 (pt) método de preparação de um fertilizante e uma composição de bactérias promotora do crescimento de plantas para adicionar a um fertilizante base
MA20150314A1 (fr) Utilisation des bactéries lactiques pour produire des substances inhibitrices de la croissance de certaines souches pathogènes

Legal Events

Date Code Title Description
FG Grant or registration